+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Are preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio prognostic factors for patients with esophageal squamous cell cancer?



Are preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio prognostic factors for patients with esophageal squamous cell cancer?



Diseases of the Esophagus 29(6): 704




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057230068

Download citation: RISBibTeXText

PMID: 25833202

DOI: 10.1111/dote.12351


Related references

Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer. Diseases of the Esophagus 29(1): 79-85, 2016

Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World Journal of Surgical Oncology 12: 58, 2014

Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy. Diseases of the Esophagus 29(5): 403-411, 2017

The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?. Therapeutic Advances in Medical Oncology 8(3): 160-167, 2016

Total lymphocyte count, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio as prognostic factors in advanced non-small cell lung cancer with chemoradiotherapy. Cancer Management and Research 10: 6677-6683, 2018

Prognostic value of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with epithelial ovarian cancer. European Journal of Gynaecological Oncology 38(3): 444-448, 2018

Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma. Oncotargets and Therapy 6: 1605-1612, 2014

Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma?. Oncotargets and Therapy 7: 433-434, 2014

Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer. Annals of Surgical Oncology 22(Suppl. 3): S603-S613, 2016

The Prognostic Factors of Lower Nadir of Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio Were Associated With Worse Treatment Outcomes in Patients With Limited-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology*biology*physics 99(2): E501-E502, 2017

Prognostic significance of preoperative and follow-up neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma. Investigative and Clinical Urology 60(1): 14-20, 2019

Preoperative neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio as new prognostic factors for patients with colorectal cancer. Journal of BUON 21(5): 1153-1157, 2017

Value of the preoperative neutrophil-to-lymphocyte ratio as a prognostic factor for long-term survival in postoperative esophageal squamous cell carcinoma patients. Thoracic Cancer 9(12): 1707-1715, 2018

Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis. Clinical Genitourinary Cancer 16(3): E685-E693, 2018

Neutrophil to lymphocyte ratio as prognostic indicator for patients with esophageal squamous cell cancer. International Journal of Biological Markers 32(4): E409-E414, 2017